Tag: robert debernardo

Study Examines Factors Associated with Non-Completion of Intraperitoneal with Intravenous Chemotherapy in Women with Epithelial Ovarian Cancer
December 5, 2019/Cancer

Factors Associated with Non-Completion of IP/IV Chemotherapy in Women with Epithelial Ovarian Cancer

Non-home discharge and higher ECOG status associated with IP/IV chemotherapy non-completion

19-OBG-1452_CQD_650x450_1

Flipping the Research Paradigm for Rare Uterine Cancers

Robert DeBernardo, MD, named Laura J. Fogarty Endowed Chair in Women's Health for Uterine Cancer Research

DeBernardo_18-OBG-198_650x450
May 16, 2019/Cancer

Anesthesia Considerations in HIPEC for Epithelial Ovarian Cancer

Careful management of adverse intraoperative events may reduce morbidity and mortality

HoloLens_650x450

HoloLens to Assess the Resectability of Ovarian Cancer

Augmented reality may improve preoperative evaluation of disease burden

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

sentinel-lymph-node_650x450
October 16, 2018/Cancer

How Sentinel Lymph Node Detection Is Improving Care for Endometrial Cancer Patients

Minimally invasive staging technique improves accuracy, reduces complications

BackPage 1 of 1Next
Advertisement
Ad